A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
Conditions
Healthy Volunteers (HV)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Parexel Early Phase Clinical Unit (EPCU), Glendale, California, United States
Study leads
Li Li, MD
Study Director
Jade Biosciences